PBS updates

Essential Care Jr (amino acid formula with fat, carbohydrate, vitamins, minerals, trace elements and medium chain triglycerides)

amino acid formula with fat, carbohydrate, vitamins, minerals, trace elements and medium chain triglycerides powder for oral liquid, 400 g · ORAL · PBS code 14797T

AUTHORITY_REQUIRED

What it costs

AU$40.47 PBS-determined price per 8 units

Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.

  • • First listed on the PBS: 2025-05-01.
  • • Repeats: 5.
  • • PBS program: GE.
Eligibility criteria for subsidised access

The following is the government's own wording from the PBS Schedule, shown unchanged.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Cows' milk protein enteropathy


Initial treatment for up to 6 months


Must be treated by a specialist allergist, clinical immunologist or specialist paediatric gastroenterologist and hepatologist, or in consultation with a specialist allergist, clinical immunologist or specialist paediatric gastroenterologist and hepatologist; AND

The condition must not be isolated infant colic or reflux; AND

Patient must be intolerant to both soy protein and protein hydrolysate formulae, as demonstrated when the child has failed to respond to a strict cows' milk protein free and strict soy protein free diet with a protein hydrolysate (with or without medium chain triglycerides) as the principal formula; AND

Patient must be up to the age of 24 months.

The name of the specialist and the date of birth of the patient must be included in the authority application.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Severe cows' milk protein enteropathy with failure to thrive


Initial treatment for up to 6 months


Must be treated by a specialist allergist, clinical immunologist or specialist paediatric gastroenterologist and hepatologist, or in consultation with a specialist allergist, clinical immunologist or specialist paediatric gastroenterologist and hepatologist; AND

The condition must not be isolated infant colic or reflux; AND

Patient must be up to the age of 24 months.

The name of the specialist and the date of birth of the patient must be included in the authority application.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Proven combined immunoglobulin E (IgE) mediated allergy to cows' milk protein and soy protein


Initial treatment for up to 6 months


Must be treated by a specialist allergist, clinical immunologist or specialist paediatric gastroenterologist and hepatologist, or in consultation with a specialist allergist, clinical immunologist or specialist paediatric gastroenterologist and hepatologist; AND

Patient must have failed a trial of protein hydrolysate formulae (with or without medium chain triglycerides); AND

Patient must be up to the age of 24 months.

The name of the specialist and the date of birth of the patient must be included in the authority application.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Cows' milk protein enteropathy


Continuing treatment


Must be treated by a specialist allergist, clinical immunologist or specialist paediatric gastroenterologist and hepatologist, or have an appointment to be assessed by one of these specialists; AND

The condition must not be isolated infant colic or reflux; AND

Patient must be intolerant to both soy protein and protein hydrolysate formulae, as demonstrated when the child has failed to respond to a strict cows' milk protein free and strict soy protein free diet with a protein hydrolysate (with or without medium chain triglycerides) as the principal formula; AND

Patient must be up to the age of 24 months.

The name of the specialist and the date of birth of the patient must be included in the authority application.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Severe cows' milk protein enteropathy with failure to thrive


Continuing treatment


Must be treated by a specialist allergist, clinical immunologist or specialist paediatric gastroenterologist and hepatologist, or have been assessed at least once or have an appointment to be assessed by one of these specialists; AND

The condition must not be isolated infant colic or reflux; AND

Patient must have had failure to thrive prior to commencement with initial treatment; AND

Patient must be up to the age of 24 months.

The name of the specialist and the date of birth of the patient must be included in the authority application.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Proven combined immunoglobulin E (IgE) mediated allergy to cows' milk protein and soy protein


Continuing treatment


Must be treated by a specialist allergist, clinical immunologist or specialist paediatric gastroenterologist and hepatologist; AND

Patient must have failed a trial of protein hydrolysate formulae (with or without medium chain triglycerides) prior to commencement with initial treatment; AND

Patient must be up to the age of 24 months.

The name of the specialist and the date of birth of the patient must be included in the authority application.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Cows' milk anaphylaxis


Must be treated by a specialist allergist or clinical immunologist, or in consultation with a specialist allergist or clinical immunologist; AND

Patient must be up to the age of 24 months.

Anaphylaxis is defined as a severe and/or potentially life threatening allergic reaction.

The name of the specialist and the date of birth of the patient must be included in the authority application.

Sponsor: Cortex Health Pty Ltd ABN 17 144 062 386

Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.